Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(29%)
Results Posted
50%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_2
2
29%
Ph not_applicable
3
43%
Ph early_phase_1
1
14%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(2)
Terminated(2)

Detailed Status

Completed2
Terminated1
Not yet recruiting1
Withdrawn1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (16.7%)
Phase 22 (33.3%)
N/A3 (50.0%)

Trials by Status

terminated114%
not_yet_recruiting114%
withdrawn114%
active_not_recruiting114%
completed229%
recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
RADIATION
Total Trials
7